Segments - Disposable Respiratory Devices Market by Product (Nebulizers, Humidifiers, Oxygen Concentrators, Ventilators, and Others), Application (Asthma, Chronic Obstructive Pulmonary Disease, Sleep Apnea, and Others), End-user (Hospitals, Clinics, Home Care Settings, Ambulatory Care Centers, Healthcare Institutes, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global disposable respiratory devices market size was USD XX Mn in 2022 and is likely to reach USD XX Mn by 2031, expanding at a CAGR of XX% during 2023–2031. Rising concerns about the risks associated with cross-contamination caused by infectious diseases among patients are propelling the market.
The COVID-19 pandemic boosted the disposable respiratory devices market. The demand for disposable respiratory devices grew significantly due to the rising concerns about the virus spreading among people. This led to a surge in the demand for such devices, as the World Health Organization declared the pandemic as an international concern for public health.
Doctors and patients across global healthcare facilities adopted breathing-assistance devices, as the COVID-19 virus specifically affected the functions of the lungs. This further increased the demand for disposable ventilators for hospitalized patients.
Disposable respiratory devices provide protection from contaminated & polluted air and help in treating numerous respiratory diseases. These devices are discarded after a single use, which prevents infection spread, this acts as a major driver for the market. The surging number of patients with respiratory problems, including lung cancer, asthma, and chronic obstructive pulmonary disease (COPD) and concerns about cross contaminations are propelling the demand for respiratory devices. For instance,
According to a report titled Lung Cancer Facts 2023 by Lung Cancer Research Foundation (LCRF), around 2,38,340 people in the US are expected to have lung cancer in 2023. The report further stated that 1 in 16 people in the US are expected to have lung cancer in their lifetime.
Respiratory diseases are usually caused by air pollution, smoking, and breathing harmful agents. Such factors further affect the efficacy of the lungs to process & provide oxygen to the body. Thus, to facilitate the healthy functioning of the lungs, disposable respiratory devices are highly being adopted by doctors & patients across the globe, which further helps in the growth of the market.
Rising prevalence of diseases associated with the respiratory system is one of the key drivers of the disposable respiratory devices market. Lifestyle habits such as smoking, increasing air pollution, and inhaling toxic agents are the major reasons for respiratory problems. For instance,
According to a report by CDC, smoking is the leading cause of more than 80% of deaths associated with lung cancer in the US. Other tobacco products including pipes or cigars are also anticipated to cause lung cancer, as they contain more than 7,000 toxic chemicals.
Increasing usage of personal protective equipment (PPE) for shielding the respiratory system against harmful elements is further driving the market. Numerous patients are adopting homecare settings for oxygen therapy and inhaled medications, which directly increases the demand for single-use respiratory devices.
High cost associated with the frequent purchasing of single-use respiratory devices is expected to restrain the market. Disposable devices lose their germ protection efficacy after a single use, which means that the patient has to use a new device often, which adds to the cost burden on their pockets. In addition, environmental concerns about the appropriate disposal of used respiratory devices and the increasing generation of medical waste are further anticipated to impede market growth.
Increasing government and private sector investments in the development of healthcare infrastructure in various emerging countries are expected to create expansion opportunities for the market players. These developments support nations to have an updated infrastructure for any future medical emergencies and prevent large mortality rates. This factor is likely to generate opportunities for the market players to manufacture innovative products.
Ongoing developments in creating point-of-care respiratory devices for patient accessibility are anticipated to create lucrative opportunities in the market. Moreover, rising investment in R&D for innovative techniques to enhance disposable respiratory devices is further projected to create growth opportunities for the market.
The report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Disposable Respiratory Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Product (Nebulizers, Humidifiers, Oxygen Concentrators, Ventilators, and Others), Application (Asthma, Chronic Obstructive Pulmonary Disease, Sleep Apnea, and Others), and End-user (Hospitals, Clinics, Home Care Settings, Ambulatory Care Centers, Healthcare Institutes, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Teleflex Incorporated; Medline Industries, LP; Fisher & Paykel Healthcare Limited; ResMed; Koninklijke Philips N.V.; Ambu A/S; Dynarex Corporation; Flexicare (Group) Limited; Inspiration Healthcare Group plc.; and BD |
Based on product, the disposable respiratory devices market is divided into nebulizers, humidifiers, oxygen concentrators, ventilators, and others. The ventilators segment is expected to expand at a significant growth rate during the projection period, due to its assured hygiene and ease of use advantages.
Disposable ventilators are usually sterile packed, which allows them to be free from harmful agents such as bacteria. They are used in invasive and non-invasive ventilation procedures, which increases the demand for ventilators by patients who prefer either of the procedures. Thus, the increasing use of disposable ventilators in severe respiratory conditions, to facilitate improved protection for the patient and medical staff is propelling the segment.
The nebulizers segment is anticipated to account for a significant market share during the forecast period, as it is a widely used device among people with lung diseases such as bronchiectasis, asthma, and cystic fibrosis. Moreover, the increasing geriatric population with pulmonary disorders and their demand for home care settings is expected to boost the segment. Cough, dyspnea, and decreased tolerance to exercise and body movements are common symptoms observed in geriatrics.
On the basis of application, the global market is segregated into asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, and others. The asthma segment is projected to register a considerable CAGR during the assessment period. The segment growth is attributed to the increasing prevalence of asthma among children and growing concerns about a rise in mortality rates caused by the disease in different age groups, including children, adults, and the geriatric population.
According to a report named Most Recent National Asthma Data by the CDC, the number of individuals aged below 18, who have asthma in the US was around 4.7 million in 2021, of which 145 deaths were reported. The high occurrence of asthma in children is attributed to their sensitive and developing immune systems.
Inhalers, nebulizers, and other single-use respiratory devices have a high demand in countries such as China, India, and Brazil, as these countries have a high number of asthma patients. This is due to urbanization and atmospheric pollution in these countries, which is further likely to boost the segment.
The COPD segment is projected to account for a significant market share in the coming years, owing to the rising occurrence of this disease among individuals in several low & middle-income countries. Rising concerns related to the surging mortality rate caused by COPD are further fueling the segment. For instance,
According to WHO, COPD caused more than 3 million deaths across the globe in 2019. The report further stated that more than 70% of COPD cases are caused by tobacco consumption and smoking in developed countries. This is due to the abnormalities occurred in the alveoli of the lungs due to tobacco.
Rising use of nebulizers and oxygen concentrators by COPD patients, for better breathing and providing optimum oxygen to the lungs is boosting the demand for disposable respiratory devices among COPD patients.
Based on end-user, the disposable respiratory devices market is segmented into hospitals, clinics, home care settings, ambulatory care centers, healthcare institutes, and others. The hospitals segment is expected to register a robust growth rate during the projection period, due to rising admission of patients with respiratory system complications. Hospitals use a large number of disposable respiratory devices to prevent cross-contamination among patients, which facilitates the increasing demand for respiratory devices.
A large number of patients require hospitalization due to severe respiratory conditions caused by pollution, allergies, and hereditary issues in various countries. This creates a global demand for disposable respiratory devices in hospital settings, which further fuels the segment.
The home care settings segment is expected to grow at a rapid pace in the coming years, due to the rising adoption of self-use devices among patients with minor respiratory problems. Such patients do not require hospitalization as they can manage efficient breathing with the help of portable respiratory devices. Thus, respiratory disposables act as a cost-effective and convenient solution for home care settings. In addition, the rising adoption of telemedicine consultation among people in urban areas is further propelling the segment.
In terms of region, the global disposable respiratory devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, as countries including the US have a high number of patients with minor and chronic respiratory diseases such as asthma and COPD. For instance,
According to the report published by the American Lung Association in 2023, more than 34 million people in the US have chronic lung diseases such as COPD and asthma. Furthermore, around 4 million children and more than 25 million adults experience breathing difficulties due to asthma in the US. These conditions are mainly caused due to improper nutrition, unhealthy lifestyles, and improper immune systems.
North America has a large number of pharmaceutical companies, which are likely to further boost their investment in producing advanced disposable respiratory devices, which further supports market expansion in the region. In addition, the presence of developed healthcare infrastructure is likely to boost the regional market.
The market in Asia Pacific is anticipated to expand at a rapid pace during the projection period, due to the ongoing developments in the government and private hospital systems in various countries of the region. The people in the region have a high incidence of respiratory issues, owing to pollution and smoking habits. Furthermore, the increasing medical tourism gives rise to the demand for disposable respiratory devices in the region.
The disposable respiratory devices market has been segmented on the basis of
Key players operating in the global disposable respiratory devices market include Teleflex Incorporated; Medline Industries, LP; Fisher & Paykel Healthcare Limited; ResMed; Koninklijke Philips N.V.; Ambu A/S; Dynarex Corporation; Flexicare (Group) Limited; Inspiration Healthcare Group plc.; and BD.
These companies adopt strategies such as acquisitions, partnerships, collaboration, mergers, R&D investments, and product launches to boost their market share. For instance,
On 28 June 2021, Medline Industries, LP, a private American-based healthcare organization, announced a partial acquisition of Hudson RCI, a respiratory products line of Teleflex Incorporated. The acquisition aims to expand the production of disposable respiratory devices by leveraging the strengths of both companies.